Hamad, Anas
Elazzazy, Shereen
Bujassoum, Salha
Rasul, Kakil
Gaziev, Javid
Cherif, Honar
Al-Boloshi, Zakiya
Hanssens, Yolande
Saleh, Ayman
Rasheed, Hadi Abu
Al-Badriyeh, Daoud
Babiker, Ahmed
Hmaidan, Amid Abu
Al-Hail, Moza
Funding for this research was provided by:
Hamad Medical Corporation
Article History
Received: 24 June 2022
Accepted: 16 December 2022
First Online: 6 January 2023
Declarations
:
: The Institutional Review Board of Hamad Medical Corporation have exempted this study from ethical review as they considered it as a service evaluation.
: All authors gave electronic consent to participate in this study and have the virtual expert panel discussion recorded.
: All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors have no conflicts of interest to disclose in relation to this manuscript. AstraZeneca personnel did not participate in writing or reviewing any part of the manuscript or in the decision to submit it for publication.